European Journal of Cancer · 2018 · 68 citations · 14 references
MedicineOncologySurgeryMetastasisTumor MicroenvironmentTumor ProgressionCutaneous Metastatic DiseaseMalignant NeoplasmsMelanocytic TumorsMetastatic Cancer ManagementMetastatic Disease ManagementMetastatic Disease TreatmentMelanocytic Tumor PrognosisMelanoma Adjuvant TherapyMelanoma ImmunotherapyMelanoma ProgressionMetastatic Melanoma TreatmentPrognosis Of Cutaneous MetastasesTreatment Of Cutaneous Metastases
14
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.4K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text
Medicine, Oncology, Pharmacotherapy +14